Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Annales De Medecine Interne|January 1, 1996
Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosusN Suzuki, T Suzuki, T Sakane
Clinical and Experimental Immunology|February 1, 1990
Effects of a novel immunosuppressive agent, FK506, on human B cell activationN Suzuki, T Sakane, T Tsunematsu
Cellular Immunology|May 1, 1997
Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitroC Sanbongi, N Suzuki, T Sakane
Arthritis and Rheumatism|July 1, 1978
Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cellsT Sakane, A D Steinberg, I Green
The Journal of Clinical Investigation|January 1, 1990
Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosusN Suzuki, T Sakane, E G Engleman
Pharmaceutical Research|May 20, 1998
Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administrationW M Pardridge, D Wu, T Sakane
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosusT Sakane, A D Steinberg, I Green
Arthritis and Rheumatism|February 1, 1986
Abnormal B cell function in patients with Behçet's diseaseN Suzuki, T Sakane, Y Ueda, et al.
Inflammation|June 1, 1985
Role of stimulated neutrophils from patients with systemic lupus erythematosus in tissue injury, with special reference to serum factors and increased active oxygen species generated by neutrophilsY Niwa, T Sakane, M Shingu, et al.
Ryumachi. [Rheumatism]|October 1, 1995
[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions]T Sakane, M Mochizuki, G Inaba, et al.
Pageof 18